Cargando…

BRMS1 in Gliomas—An Expression Analysis

SIMPLE SUMMARY: Gliomas are the most common primary brain tumors and are associated with significant mortality and morbidity. Less than 5% of patients with glioblastoma, the most common glioma histology, survive longer than five years. Therefore, searching for new biomarkers/molecular targets remain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feldheim, Jonas, Kessler, Almuth F., Feldheim, Julia J., Schmitt, Dominik, Oster, Christoph, Lazaridis, Lazaros, Glas, Martin, Ernestus, Ralf-Ingo, Monoranu, Camelia M., Löhr, Mario, Hagemann, Carsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252102/ https://www.ncbi.nlm.nih.gov/pubmed/37296870 http://dx.doi.org/10.3390/cancers15112907

Ejemplares similares

Monopolar Spindle 1 Kinase (MPS1/TTK) mRNA Expression is Associated with Earlier Development of Clinical Symptoms, Tumor Aggressiveness and Survival of Glioma Patients
por: Kessler, Almuth F., et al.
Publicado: (2020)

Ribosomal Protein S27/Metallopanstimulin-1 (RPS27) in Glioma—A New Disease Biomarker?
por: Feldheim, Jonas, et al.
Publicado: (2020)

Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells
por: Feldheim, Jonas, et al.
Publicado: (2022)

Changes of O(6)-Methylguanine DNA Methyltransferase (MGMT) Promoter Methylation in Glioblastoma Relapse—A Meta-Analysis Type Literature Review
por: Feldheim, Jonas, et al.
Publicado: (2019)

Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patients
por: Feldheim, Jonas, et al.
Publicado: (2018)

Metastasis Associated in Colorectal Cancer 1 (MACC1) mRNA Expression Is Enhanced in Sporadic Vestibular Schwannoma and Correlates to Deafness
por: Breun, Maria, et al.
Publicado: (2023)

Protocadherin Gamma C3 (PCDHGC3) Is Strongly Expressed in Glioblastoma and Its High Expression Is Associated with Longer Progression-Free Survival of Patients
por: Feldheim, Jonas, et al.
Publicado: (2022)

Telemedicine in Neuro-Oncology—An Evaluation of Remote Consultations during the COVID-19 Pandemic
por: Feldheim, Jonas, et al.
Publicado: (2023)

Long-term tumor control of spinal dissemination of cerebellar glioblastoma multiforme by combined adjuvant bevacizumab antibody therapy: a case report
por: Linsenmann, Thomas, et al.
Publicado: (2014)

Tumor growth under rhGM-CSF application in an orthotopic rodent glioma model
por: Linsenmann, Thomas, et al.
Publicado: (2019)

Primary brain amyloidoma, both a neoplastic and a neurodegenerative disease: a case report
por: Löhr, Mario, et al.
Publicado: (2019)

CXCR4: A new player in vestibular schwannoma pathogenesis
por: Breun, Maria, et al.
Publicado: (2018)

Glioblastoma-Derived Three-Dimensional Ex Vivo Models to Evaluate Effects and Efficacy of Tumor Treating Fields (TTFields)
por: Nickl, Vera, et al.
Publicado: (2022)

Analysis of ADAM9 regulation and function in vestibular schwannoma primary cells
por: Nattmann, Anja, et al.
Publicado: (2020)

High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with T(reg) depletion
por: Löhr, Mario, et al.
Publicado: (2018)

Circulating MACC1 Transcripts in Glioblastoma Patients Predict Prognosis and Treatment Response
por: Hagemann, Carsten, et al.
Publicado: (2019)

Characterization and Optimization of the Tumor Microenvironment in Patient-Derived Organotypic Slices and Organoid Models of Glioblastoma
por: Nickl, Vera, et al.
Publicado: (2023)

Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition
por: Kessler, Almuth F., et al.
Publicado: (2018)

[(68)Ga]-Pentixafor PET/CT for CXCR4-Mediated Imaging of Vestibular Schwannomas
por: Breun, Maria, et al.
Publicado: (2019)

Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier
por: Salvador, Ellaine, et al.
Publicado: (2023)

Bone chips, fibrin glue, and osteogeneration following lateral suboccipital craniectomy: a case report
por: Linsenmann, Thomas, et al.
Publicado: (2013)

Expression-analysis of the human endogenous retrovirus HERV-K in human astrocytic tumors
por: Kessler, Almuth Friederike, et al.
Publicado: (2014)

ADAM9: A novel player in vestibular schwannoma pathogenesis
por: Breun, Maria, et al.
Publicado: (2020)

Malignant transformation of a cerebral dermoid cyst into a squamous cell carcinoma with malignant intraperitoneal spreading along a ventriculoperitoneal shunt: illustrative case
por: Nickl, Robert C., et al.
Publicado: (2022)

Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma
por: Schmidt, Teresa, et al.
Publicado: (2023)

(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma
por: Lapa, Constantin, et al.
Publicado: (2016)

Primary Spinal Glioblastoma Multiforme with Secondary Manifestation as a Cerebral “Angioglioma.” Literature Review and Case Report
por: Linsenmann, Thomas, et al.
Publicado: (2015)

Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodies
por: Feldheim, Jonas, et al.
Publicado: (2021)

Tumor Treating Fields (TTFields) Reversibly Permeabilize the Blood–Brain Barrier In Vitro and In Vivo
por: Salvador, Ellaine, et al.
Publicado: (2022)

BRMS1 Suppresses Glioma Progression by Regulating Invasion, Migration and Adhesion of Glioma Cells
por: Mei, Pengjin, et al.
Publicado: (2014)

Tumor-Associated Macrophages in Glioblastoma Multiforme—A Suitable Target for Somatostatin Receptor-Based Imaging and Therapy?
por: Lapa, Constantin, et al.
Publicado: (2015)

First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastoma
por: Lazaridis, Lazaros, et al.
Publicado: (2022)

Retraction: BRMS1 Suppresses Glioma Progression by Regulating Invasion, Migration and Adhesion of Glioma Cells
Publicado: (2022)

Case Report: A Case Series Using Natural Anatomical Gaps—Posterior Cervical Approach to Skull Base and Upper Craniocervical Meningiomas Without Bone Removal
por: Lilla, Nadine, et al.
Publicado: (2021)

Analysis of microRNAs in Exosomes of Breast Cancer Patients in Search of Molecular Prognostic Factors in Brain Metastases
por: Curtaz, Carolin J., et al.
Publicado: (2022)

Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood–brain barrier model
por: Curtaz, Carolin J., et al.
Publicado: (2020)

Expression of the metastasis suppressor BRMS1 in uveal melanoma
por: Ventura, Bruna V, et al.
Publicado: (2014)

Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005–2022
por: Oster, Christoph, et al.
Publicado: (2023)

Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma
por: Lazaridis, Lazaros, et al.
Publicado: (2022)

Location, location, location: the BRMS1 protein and melanoma progression
por: Riker, Adam I, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tc2repfj0g2vgkdvvp3c75t7m7